Why Reliability Is Now a Business Metric 
The Startup Reckoning: Why Healthcare AI Now Demands Industry-Built Founders 
0G Introduces Sealed Inference: Cryptographically Private AI Where Every Response Is Verified Inside a Hardware Enclave iTeos Therapeutics Announces New Preliminary Data Indicating Clinical Activity with its Anti-TIGIT Antibody, EOS-448, at the AACR Annual Meeting 2021
Initial data from the Phase 1 dose escalation part of the Phase 1/2a trial in…
Gennao Bio Presents New Data on Novel Gene Monoclonal Antibody Platform Technology at the American Association for Cancer Research (AACR) 2021 Annual Meeting
~ Preclinical data show the utility of Gennao’s proprietary first-in-class monoclonal antibody 3E10-D31N (GMABD31N), a…
MacroGenics Announces Presentations at the 2021 AACR Annual Meeting
ROCKVILLE, MD, April 10, 2021 (GLOBE NEWSWIRE) — MacroGenics, Inc. (Nasdaq: MGNX), a biopharmaceutical company focused…
Kronos Bio Presents Preclinical Data for Oral CDK9 Inhibitor KB-0742 Demonstrating Sustained Inhibition of Tumor Growth in Multiple Cancers at AACR Annual Meeting 2021
MYC genomic amplification found to be a key driver of sensitivity to CDK9 inhibition Pan-cancer…
Allogene Therapeutics Presents Preclinical Research Highlighting a Novel TurboCAR™ T Cell Technology Designed to Overcome Immune Suppression in Solid Tumors at the American Association for Cancer Research (AACR) Virtual 2021 Meeting
Proprietary TurboCAR Technology Platform Allows Cytokine Activation Signaling to be Selectively Engineered into AlloCAR T™ Cells…
Black Diamond Therapeutics Announces Preclinical Data Presentations on BDTX-189 and BDTX-1535 at American Association for Cancer Research Annual Meeting
CAMBRIDGE, Mass. and NEW YORK, April 10, 2021 (GLOBE NEWSWIRE) — Black Diamond Therapeutics, Inc….
Bolt Biotherapeutics Announces AACR 2021 Presentation of Boltbody™ Platform Mechanism of Action and Clinical Properties of Lead ISAC, BDC-1001
Bolt’s first-in-class clinical candidate, BDC-1001, is a novel HER2-targeting, TLR 7/8 immune-stimulating antibody conjugate (ISAC)…
Kymera Therapeutics Presents Late-Breaking Preclinical Data Highlighting Superiority of Dual-Targeting Activity of IRAKIMiD Degrader KT-413 at AACR Annual Meeting 2021
KT-413-mediated degradation of IRAK4 and IMiD substrates has synergistic effect on MYD88-NFkB and IRF4-Type 1…
Else Nutrition Issues Shares for Services
VANCOUVER, BC / ACCESSWIRE / April 10, 2021 / ELSE NUTRITION HOLDINGS INC. (TSXV:BABY)(OTCQX:BABYF)(FSE:0YL) (“Else”…
Pieris Pharmaceuticals Presents Updated Phase 1 Monotherapy Data for 4-1BB/HER2 Bispecific Cinrebafusp Alfa and Preclinical Data for 4-1BB/PD-L1 Bispecific PRS-344/S095012 at 2021 AACR Annual Meeting
Additional, ongoing confirmed durable partial response and three additional patients with stable disease as best…
Meet Jatin Naran, Making It Huge In the World of Content Creation and Business
WEMBLEY, ENGLAND / ACCESSWIRE / April 10, 2021 / The young business talent has been…
Molecular Partners Shares New Preclinical Data from its AML-Focused CD3 T-Cell Engager Program, CD40 Product Candidate MP0317, and Other Novel Immuno-oncology Approaches at AACR
Data support potential of DARPin® CD3 T-cell engager candidate for improved safety window while limiting…
China and Brazil Both Celebrate as World’s First Cross-Sea SkyRail Rolls off Production Line
SHENZHEN, CHINA, Apr 11, 2021 – (ACN Newswire) – On April 8th, BYD ushered in…
American IRA Discusses How to Think About Self-Directed SIMPLE-IRAs
CHARLOTTE, NC / ACCESSWIRE / April 10, 2021 / For some retirement investors, simply thinking…
Petroteq Announces Equity Raise, Debenture Amendment and Debt Conversions
SHERMAN OAKS, CA / ACCESSWIRE / April 9, 2021 / Petroteq Energy Inc. (“Petroteq” or…
Valneva Announces Publication of 2020 Universal Registration Document and Provides Business Updates
Saint-Herblain (France), April 10, 2021 – Valneva SE (“Valneva” or the “Company”), a specialty vaccine…
Valneva Files Registration Statement for Proposed United States Initial Public Offering
Saint-Herblain (France), April 10, 2021 – Valneva SE (the “Company”), a specialty vaccine company focused…
Biogen Announces Two New Nominees for Election to Board of Directors
Nominees bring diverse business and public health experience key to Biogen’s mission to pioneer and…
Genmab and Seagen Announce U.S. FDA Filing Acceptance for Priority Review of Tisotumab Vedotin Biologics License Application for Patients with Recurrent or Metastatic Cervical Cancer
Company Announcement FDA action date is Oct 10, 2021 BLA submission supported by positive pivotal…
Scilex Holding, a Subsidiary of Sorrento, Has Received From FDA a sNDA Approval for ZTlido® Label Expansion
PALO ALTO, Calif., April 09, 2021 (GLOBE NEWSWIRE) — Scilex Holding (“Scilex”), an over 99%…